- Low-Scale Expression and Purification of an Active Putative Iduronate 2-Sulfate Sulfatase-Like Enzyme from Escherichia coli K12
-
Edwin David Morales-Álvarez , Claudia Marcela Rivera-Hoyos , Angélica María Baena-Moncada , Patricia Landázuri , Raúl A. Poutou-Piñales , Homero Sáenz-Suárez , Luis A. Barrera , Olga Y. Echeverri-Peña
-
J. Microbiol. 2013;51(2):213-221. Published online April 27, 2013
-
DOI: https://doi.org/10.1007/s12275-013-2416-2
-
-
788
View
-
1
Download
-
13
Crossref
-
 Abstract
 PDF
-
The sulfatase family involves a group of enzymes with a large degree of similarity. Until now, sixteen human sulfatases have been identified, most of them found in lysosomes. Human deficiency of sulfatases generates various genetic disorders
characterized by abnormal accumulation of sulfated intermediate compounds. Mucopolysaccharidosis type II is characterized by the deficiency of iduronate 2-sulfate sulfatase (IDS), causing the lysosomal accumulation of heparan and
dermatan sulfates. Currently, there are several cases of genetic diseases treated with enzyme replacement therapy, which have generated a great interest in the development of systems for recombinant protein expression. In this work we expressed the human recombinant IDS-Like enzyme (hrIDS-Like) in Escherichia coli DH5α. The enzyme concentration revealed by ELISA varied from 78.13 to 94.35 ng/ml and the specific activity varied from 34.20 to 25.97 nmol/h/mg. Western blotting
done after affinity chromatography purification showed a single band of approximately 40 kDa, which was recognized by an IgY polyclonal antibody that was developed against the specific peptide of the native protein. Our 100 ml-shake-flask
assays allowed us to improve the enzyme activity seven fold, compared to the E. coli JM109/pUC13-hrIDS-Like system. Additionally, the results obtained in the present study were equal to those obtained with the Pichia pastoris GS1115/
pPIC-9-hrIDS-Like system (3 L bioreactor scale). The system used in this work (E. coli DH5α/pGEX-3X-hrIDS-Like) emerges as a strategy for improving protein expression and purification, aimed at recombinant protein chemical characterization,
future laboratory assays for enzyme replacement therapy, and as new evidence of active putative sulfatase production in E. coli.
-
Citations
Citations to this article as recorded by  - A review on computational models for predicting protein solubility
Teerapat Pimtawong, Jun Ren, Jingyu Lee, Hyang-Mi Lee, Dokyun Na
Journal of Microbiology.2025; 63(1): e:2408001. CrossRef - Enhancement of the solubility of recombinant proteins by fusion with a short-disordered peptide
Jun Ren, Suhee Hwang, Junhao Shen, Hyeongwoo Kim, Hyunjoo Kim, Jieun Kim, Soyoung Ahn, Min-gyun Kim, Seung Ho Lee, Dokyun Na
Journal of Microbiology.2022; 60(9): 960. CrossRef - Characterization of mouse di-N-acetylchitobiase that can degrade chitin-oligosaccharides
Misa Ohno, Masao Miyazaki, Masahiro Kimura, Yusaku Minowa, Masayoshi Sakaguchi, Fumitaka Oyama, Tetsuro Yamashita
Bioscience, Biotechnology, and Biochemistry.2020; 84(12): 2499. CrossRef - Lysosomal sulfatases: a growing family
Torben Lübke, Markus Damme
Biochemical Journal.2020; 477(20): 3963. CrossRef - Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment
Francesca D’Avanzo, Laura Rigon, Alessandra Zanetti, Rosella Tomanin
International Journal of Molecular Sciences.2020; 21(4): 1258. CrossRef - Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
Kazuki Sawamoto, Molly Stapleton, Carlos J. Alméciga-Díaz, Angela J. Espejo-Mojica, Juan Camilo Losada, Diego A. Suarez, Shunji Tomatsu
Drugs.2019; 79(10): 1103. CrossRef - Production and characterization of a human lysosomal recombinant iduronate‐2‐sulfatase produced inPichia pastoris
Natalia Pimentel, Alexander Rodríguez‐Lopez, Sergio Díaz, Juan C. Losada, Dennis J. Díaz‐Rincón, Carolina Cardona, Ángela J. Espejo‐Mojica, Aura M. Ramírez, Fredy Ruiz, Patricia Landázuri, Raúl A. Poutou‐Piñales, Henry A. Cordoba‐Ruiz, Carlos J. Alméciga‐
Biotechnology and Applied Biochemistry.2018; 65(5): 655. CrossRef - Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years’ experience from a reference center
Olga Y. Echeverri, Johana M. Guevara, Ángela J. Espejo-Mojica, Andrea Ardila, Ninna Pulido, Magda Reyes, Alexander Rodriguez-Lopez, Carlos J. Alméciga-Díaz, Luis A. Barrera
Orphanet Journal of Rare Diseases.2018;[Epub] CrossRef - Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N -acetylgalactosamine-6-sulfate sulfatase (GALNS)
Carlos Javier Alméciga-Díaz, Andrés Dario Tolosa-Díaz, Luisa Natalia Pimentel, Yahir Andres Bonilla, Alexander Rodríguez-López, Angela J. Espejo-Mojica, Juan D. Patiño, Oscar F. Sánchez, Janneth Gonzalez-Santos
Gene.2017; 634: 53. CrossRef - Prediction of glycation sites: new insights from protein structural analysis
Homero SÁENZ-SUÁREZ, Raúl A. POUTOU-PIÑALES, Janneth GONZÁLEZ-SANTOS, George E. BARRETO, Lynda P. RIETO-NAVARRERA, José A. SÁENZ-MORENO, Patricia LANDÁZURI, Luis A. BARRERA-AVELLANEDA
TURKISH JOURNAL OF BIOLOGY.2016; 40: 12. CrossRef - Bioinformatic Analysis of the Human Recombinant Iduronate 2-Sulfate Sulfatase
Edwin D. Morales-Álvarez, Claudia M. Rivera-Hoyos, Patricia Landázuri, Raúl A. Poutou-Piñales, Aura M. Pedroza-Rodríguez
The Open Microbiology Journal.2016; 10(1): 124. CrossRef - Human recombinant lysosomal enzymes produced in microorganisms
Ángela J. Espejo-Mojica, Carlos J. Alméciga-Díaz, Alexander Rodríguez, Ángela Mosquera, Dennis Díaz, Laura Beltrán, Sergio Díaz, Natalia Pimentel, Jefferson Moreno, Jhonnathan Sánchez, Oscar F. Sánchez, Henry Córdoba, Raúl A. Poutou-Piñales, Luis A. Barre
Molecular Genetics and Metabolism.2015; 116(1-2): 13. CrossRef - Choline sulfatase from Ensifer (Sinorhizobium) meliloti: Characterization of the unmodified enzyme
Juan José Sánchez-Romero, Luis F. Olguin
Biochemistry and Biophysics Reports.2015; 3: 161. CrossRef
|
MSK
